Hypercalcaemia of malignancy and Urinary retention

Summary:

Urinary retention is found among people with Hypercalcaemia of malignancy, especially for people who are female, 60+ old.

The study analyzes which people have Urinary retention with Hypercalcaemia of malignancy. It is created by eHealthMe based on reports of 11 people who have Hypercalcaemia of malignancy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypercalcaemia of malignancy?

Hypercalcaemia of malignancy (elevated calcium (ca+) level in the blood with cancer) is found to be associated with 88 drugs and 111 conditions by eHealthMe. Check the latest studies of Hypercalcaemia of malignancy.

What is Urinary retention?

Urinary retention (the inability to completely or partially empty the bladder) is found to be associated with 1,569 drugs and 1,737 conditions by eHealthMe. Check the latest studies of Urinary retention.

On Jul, 20, 2026

11 people who have Hypercalcaemia Of Malignancy and Urinary Retention are studied.

Would you have Urinary retention when you have Hypercalcaemia of malignancy?

Gender of people who have Hypercalcaemia Of Malignancy and experienced Urinary Retention *:

female: 60 %
male: 40 %

Age of people who have Hypercalcaemia Of Malignancy and experienced Urinary Retention *:

Common co-existing conditions for these people *:

Gastrointestinal Stromal Tumor: 1 person, 9.09%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 9.09%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 1 person, 9.09%

Common drugs taken by these people *:

Common symptoms for these people *:

Weight Decreased: 7 people, 63.64%
Weakness: 7 people, 63.64%
Pain: 7 people, 63.64%
Osteonecrosis Of Jaw (death of bone of jaw): 7 people, 63.64%
Mitral Valve Incompetence (inefficient heart valve): 7 people, 63.64%
Metastases To Bone (cancer spreads to bone): 7 people, 63.64%
Infection: 7 people, 63.64%
High Blood Pressure: 7 people, 63.64%
Fatigue (feeling of tiredness): 7 people, 63.64%
Pain In Jaw: 7 people, 63.64%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Urinary retention?

- Check whether Urinary retention is associated with a drug or a condition

Related publications that referenced our studies

Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .

Related studies:

Treatments, associated drugs and conditions:

Hypercalcaemia of malignancy (1,132 reports)
Urinary retention (42,974 reports)

All the drugs that are associated with Urinary retention:

Urinary retention (1,569 drugs)

All the conditions that are associated with Urinary retention:

Urinary retention (1,737 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Urinary retention and Hypercalcaemia of malignancy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.